Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kilpatrick

Showing results (451-460 of 471) with videos related to

Pageof 48
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Obstetrics and Gynecology|June 8, 2022
Care Levels for Fetal Therapy CentersAhmet A Baschat, Sean B Blackwell, Debnath Chatterjee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Genome Medicine|December 10, 2025
Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotypeNicholas B Blackburn, Bennet J McComish, Allan Motyer, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
The Medical Journal of Australia|July 31, 2015
A new era in the treatment of multiple sclerosisSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Annals of Neurology|October 10, 2025
Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis OnsetSteve Simpson-Yap, Ellen Morwitch, Samuel A Tanner, et al.
Geohealth|April 22, 2026
All Hazards Great and Small: Applying Disaster Risk Reduction to Environmental Justice Communities in South CarolinaDaniel J Kilpatrick, Keisha D Long, Omar Muhammad, et al.
Genes and Immunity|February 22, 2008
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African AmericansJ A Kelly, J M Kelley, K M Kaufman, et al.
Brain : a Journal of Neurology|November 30, 2022
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severityVilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, et al.
Pageof 48

Showing results (451-460 of 471) with videos related to

Sort By:
Pageof 48
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 3, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Obstetrics and Gynecology|June 8, 2022
Care Levels for Fetal Therapy CentersAhmet A Baschat, Sean B Blackwell, Debnath Chatterjee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Genome Medicine|December 10, 2025
Rare variation in neurological disease genes and its role in multiple sclerosis mimicry and phenotypeNicholas B Blackburn, Bennet J McComish, Allan Motyer, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 5, 2014
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of NeurologistsSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
The Medical Journal of Australia|July 31, 2015
A new era in the treatment of multiple sclerosisSimon A Broadley, Michael H Barnett, Mike Boggild, et al.
Annals of Neurology|October 10, 2025
Epstein-Barr Virus, Lower Vitamin D, Low Sun Exposure, and HLA-DRB1*1501 Risk Variant Share Common Epigenetic Pathways Leading to Multiple Sclerosis OnsetSteve Simpson-Yap, Ellen Morwitch, Samuel A Tanner, et al.
Geohealth|April 22, 2026
All Hazards Great and Small: Applying Disaster Risk Reduction to Environmental Justice Communities in South CarolinaDaniel J Kilpatrick, Keisha D Long, Omar Muhammad, et al.
Genes and Immunity|February 22, 2008
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African AmericansJ A Kelly, J M Kelley, K M Kaufman, et al.
Brain : a Journal of Neurology|November 30, 2022
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severityVilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, et al.
Pageof 48